GW Gets Two Cannabis-Based Meds Backed By NICE
Epidyolex And Sativex Recommended
Two cannabis-based drugs developed by GW Pharmaceuticals have been approved for use on the NHS in England for the first time and will be prescribed to patients with epilepsy and multiple sclerosis.
